Eli Lilly Close to Acquiring Verve Therapeutics for Up to USD 1.3 Billion
US-based pharmaceutical giant Eli Lilly & Co., (NYSE: LLY) is reportedly in advanced negotiations to...
Pediatrix Therapeutics Wins Macau Approval for Neffy Epinephrine Nasal Spray
China-based Pediatrix Therapeutics announced that it has received marketing approval in Macau for its neffy...
Minova Pharmaceuticals Launches Rongzhi, China’s First Injectable Adipocytolytic Drug
Nanjing-based Minova Pharmaceuticals Co., Ltd announced last week that it has received marketing approval from...
RemeGen Secures 1,827-Day Patent Extension for Telitacicept in China
China-based pharmaceutical firm RemeGen (HKG: 9995) announced that the China National Intellectual Property Administration has...
Fujian Cosunter Gains Ethics Approval for Phase III Study of Neracorvir in CHB Patients
China-based Fujian Cosunter Pharmaceutical Co., Ltd. (SHE: 300436) announced that it has received ethical approval...
CDE Accepts NDA for Ark Bio’s Azstarys, a Priority-Reviewed ADHD Treatment
China’s Center for Drug Evaluation (CDE) has officially accepted the New Drug Application (NDA) for...
Ascentage Pharma Highlights Hematology Advances at EHA 2025, Focus on Olverembatinib and APG-5918
China-based Ascentage Pharma (NASDAQ: AAPG, HKG: 6855) unveiled 13 research presentations at the 2025 European...
Clover Biopharmaceuticals Terminates Adimmune Influenza Vaccine Pact Over Market Shifts
China-based Clover Biopharmaceuticals Ltd., (HKG: 2197) announced the exercise of unilateral termination rights under its...
Fosun Pharma’s Serplulimab Approved in Singapore and Malaysia for ES-SCLC Treatment
Shanghai-based Fosun Pharmaceutical (Group) Co., Ltd. (HKG: 2196, SHA: 600196) announced that its subsidiary Shanghai...
China’s NHC Unveils 2025 Healthcare Reforms to Tackle Procurement and Service Irregularities
China’s National Health Commission (NHC) has released the 2025 Key Tasks for Rectifying Improper Practices...
Thermo Fisher Mulls $4B Diagnostic Business Sale Amid Healthcare Sector Turbulence
US-based life sciences giant Thermo Fisher Scientific Inc. (NYSE: TMO) is reported by the Financial...
Changchun High-Tech Subsidiary Gains NMPA Approval for CINV Drug Trial
China-based Changchun High & New Technology Industries (Group) Inc. (SHE: 000661) announced that its subsidiary...
Novo Nordisk Advances Amycretin for Weight Management in Phase III Trials
Denmark-based pharmaceutical major Novo Nordisk (NYSE: NVO) announced plans to advance both subcutaneous and oral...
FDA OKs MSD’s Keytruda for Perioperative Head and Neck Cancer Treatment With PD-L1 Expression
US pharmaceutical giant Merck, Sharp & Dohme (MSD; NYSE: MRK) announced that the US Food...
GSK Seeks EMA Approval to Expand RSV Vaccine Arexvy Use to Adults Aged 18+
UK-based pharmaceutical giant GlaxoSmithKline (GSK, NYSE: GSK) has announced that the European Medicines Agency (EMA)...
UCB Announces Investment in U.S. Biologics Production Facility
Belgium-based biopharmaceutical company UCB (EBR: UCB) announced plans to invest in a cutting-edge biologics production...
Gene Solutions Partners with Shenzhen USK Bio to Advance Precision Oncology in Southern China
Vietnam-headquartered Gene Solutions announced a Memorandum of Understanding (MOU) with China’s Shenzhen USK Bioscience Co.,...
MRI and Astellas Alliance to Boost Japanese Drug Discovery Startups
Japan-based Mitsubishi Research Institute, Inc. (MRI) and Astellas Pharma Inc. (TYO: 4503) announced the signing...
MSD Wins NMPA Approval for Keytruda-Lenvima Combo in Hepatocellular Carcinoma
US-based Merck, Sharp & Dohme (MSD; NYSE: MRK) announced that China’s National Medical Products Administration...
Xuanzhu Biopharma Files for Hong Kong IPO to Advance Innovative Drug Pipeline
Xuanzhu Biopharmaceutical Co., Ltd., a subsidiary of China’s Sihuan Pharmaceutical Holdings Group Ltd (HKG: 0460),...